Search research articles
Contact Us
Filters
Showing results (31-40 of 139) with videos related to
Page
of 14
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 3, 2016
HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers
Bob T Li, Dara S Ross, Dara L Aisner, et al.
Ophthalmology. Retina
|
June 8, 2021
Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated Retinopathy
Jasmine H Francis, Julia Canestraro, Dianna Haggag-Lindgren, et al.
Frontiers in Oncology
|
October 21, 2024
Case report: dynamic personalized physiological monitoring in lung cancer using wearable data
Joshua W Bliss, Whitney P Underwood, Adele M Carlson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2019
Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System Metastases
Aki Morikawa, Elisa de Stanchina, Elena Pentsova, et al.
The Oncologist
|
November 18, 2017
Therapeutic Potential of Afatinib for Cancers with <i>ERBB2</i> (<i>HER2</i>) Transmembrane Domain Mutations G660D and V659E
Hiromasa Yamamoto, Shinichi Toyooka, Takashi Ninomiya, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2021
Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
David L Chan, Gary A Ulaner, David Pattison, et al.
JAMA Network Open
|
December 9, 2025
Risk and Outcomes of Secondary Cancer Among Lung Cancer Survivors After Definitive Treatment
Matthew T McMillan, Orly Yariv, Sana Raoof, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 27, 2019
Lessons learned from routine, targeted assessment of liquid biopsies for <i>EGFR</i> T790M resistance mutation in patients with <i>EGFR</i> mutant lung cancers
Sebastian Mondaca, Michael Offin, Laetitia Borsu, et al.
Cancers
|
August 7, 2021
The Emerging Importance of Tumor Genomics in Operable Non-Small Cell Lung Cancer
Harry B Lengel, James G Connolly, Gregory D Jones, et al.
Translational Lung Cancer Research
|
October 24, 2025
Radiomic phenotypes of oligometastatic non-small cell lung cancer
Kevin M Boehm, Emily S Lebow, N Ari Wijetunga, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 139) with videos related to
Sort By:
Page
of 14
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 3, 2016
HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers
Bob T Li, Dara S Ross, Dara L Aisner, et al.
Ophthalmology. Retina
|
June 8, 2021
Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated Retinopathy
Jasmine H Francis, Julia Canestraro, Dianna Haggag-Lindgren, et al.
Frontiers in Oncology
|
October 21, 2024
Case report: dynamic personalized physiological monitoring in lung cancer using wearable data
Joshua W Bliss, Whitney P Underwood, Adele M Carlson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2019
Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System Metastases
Aki Morikawa, Elisa de Stanchina, Elena Pentsova, et al.
The Oncologist
|
November 18, 2017
Therapeutic Potential of Afatinib for Cancers with <i>ERBB2</i> (<i>HER2</i>) Transmembrane Domain Mutations G660D and V659E
Hiromasa Yamamoto, Shinichi Toyooka, Takashi Ninomiya, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2021
Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
David L Chan, Gary A Ulaner, David Pattison, et al.
JAMA Network Open
|
December 9, 2025
Risk and Outcomes of Secondary Cancer Among Lung Cancer Survivors After Definitive Treatment
Matthew T McMillan, Orly Yariv, Sana Raoof, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 27, 2019
Lessons learned from routine, targeted assessment of liquid biopsies for <i>EGFR</i> T790M resistance mutation in patients with <i>EGFR</i> mutant lung cancers
Sebastian Mondaca, Michael Offin, Laetitia Borsu, et al.
Cancers
|
August 7, 2021
The Emerging Importance of Tumor Genomics in Operable Non-Small Cell Lung Cancer
Harry B Lengel, James G Connolly, Gregory D Jones, et al.
Translational Lung Cancer Research
|
October 24, 2025
Radiomic phenotypes of oligometastatic non-small cell lung cancer
Kevin M Boehm, Emily S Lebow, N Ari Wijetunga, et al.
Page
of 14